Diffuse Large B-Cell Lymphoma — Trials

Diffuse Large B-Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

1,150 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 355
Recruiting: 190
Ph III recruiting: 16
Growth YoY: −11.6%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (177)

clinicaltrialsPublishedShowing 1–17 of 17 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06290622	PD-1, LAG-3 and TIM-3 Checkpoint Blockade in DLBCL	withdrawn	Phase 1	0	University of Alabama at BirminghamOTHER	0	May 6, 2025	clinicaltrials
NCT04052061	QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma	withdrawn	Phase 1	0	ImmunityBio, Inc.INDUSTRY	1	Feb 21, 2025	clinicaltrials
NCT04995536